Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Damien Sanlaville is active.

Publication


Featured researches published by Damien Sanlaville.


Journal of Medical Genetics | 2004

Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features

Charles Shaw-Smith; Richard Redon; Lisa Rickman; Marlène Rio; Lionel Willatt; Heike Fiegler; Helen V. Firth; Damien Sanlaville; R Winter; Laurence Colleaux; M Bobrow; Nigel P. Carter

The underlying causes of learning disability and dysmorphic features in many patients remain unidentified despite extensive investigation. Routine karyotype analysis is not sensitive enough to detect subtle chromosome rearrangements (less than 5 Mb). The presence of subtle DNA copy number changes was investigated by array-CGH in 50 patients with learning disability and dysmorphism, employing a DNA microarray constructed from large insert clones spaced at approximately 1 Mb intervals across the genome. Twelve copy number abnormalities were identified in 12 patients (24% of the total): seven deletions (six apparently de novo and one inherited from a phenotypically normal parent) and five duplications (one de novo and four inherited from phenotypically normal parents). Altered segments ranged in size from those involving a single clone to regions as large as 14 Mb. No recurrent deletion or duplication was identified within this cohort of patients. On the basis of these results, we anticipate that array-CGH will become a routine method of genome-wide screening for imbalanced rearrangements in children with learning disability.


Journal of Medical Genetics | 2005

Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development

Damien Sanlaville; Heather Etchevers; Marie Gonzales; Jelena Martinovic; Mathieu Clément-Ziza; Anne-Lise Delezoide; Marie-Cécile Aubry; Anna Pelet; Sophie Chemouny; Corinne Cruaud; Sophie Audollent; Chantal Esculpavit; Géraldine Goudefroye; Catherine Ozilou; Catherine Fredouille; Nicole Joyé; Nicole Morichon-Delvallez; Yves Dumez; Jean Weissenbach; Arnold Munnich; Jeanne Amiel; Férechté Encha-Razavi; Stanislas Lyonnet; Michel Vekemans; Tania Attié-Bitach

Background: The acronym CHARGE refers to a non-random cluster of malformations including coloboma, heart malformation, choanal atresia, retardation of growth and/or development, genital anomalies, and ear anomalies. This set of multiple congenital anomalies is frequent, despite rare patients with normal intelligence, and prognosis remains poor. Recently, CHD7 gene mutations have been identified in CHARGE patients; however, the function of CHD7 during development remains unknown. Methods: We studied a series of 10 antenatal cases in whom the diagnosis of CHARGE syndrome was suspected, considering that a careful pathological description would shed light on the CHD7 function during development. CHD7 sequence analysis and in situ hybridisation were employed. Results: The diagnosis of CHARGE syndrome was confirmed in all 10 fetuses by the identification of a CHD7 heterozygous truncating mutation. Interestingly, arhinencephaly and semi-circular canal agenesis were two constant features which are not included in formal diagnostic criteria so far. In situ hybridisation analysis of the CHD7 gene during early human development emphasised the role of CHD7 in the development of the central nervous system, internal ear, and neural crest of pharyngeal arches, and more generally showed a good correlation between specific CHD7 expression pattern and the developmental anomalies observed in CHARGE syndrome. Conclusions: These results allowed us to further refine the phenotypic spectrum of developmental anomalies resulting from CHD7 dysfunction.


American Journal of Human Genetics | 2008

Submicroscopic Duplications of the Hydroxysteroid Dehydrogenase HSD17B10 and the E3 Ubiquitin Ligase HUWE1 Are Associated with Mental Retardation

Guy Froyen; Mark Corbett; Joke Vandewalle; Irma Järvelä; O Lawrence; Cliff Meldrum; Marijke Bauters; Karen Govaerts; Lucianne Vandeleur; Hilde Van Esch; Jamel Chelly; Damien Sanlaville; Hans van Bokhoven; Hans-Hilger Ropers; Frédéric Laumonnier; Enzo Ranieri; Charles E. Schwartz; Fatima Abidi; Patrick Tarpey; P. Andrew Futreal; Annabel Whibley; F. Lucy Raymond; Michael R. Stratton; Jean Pierre Fryns; Rodney J. Scott; Maarit Peippo; Marjatta Sipponen; Michael Partington; David Mowat; Michael Field

Submicroscopic copy-number imbalances contribute significantly to the genetic etiology of human disease. Here, we report a novel microduplication hot spot at Xp11.22 identified in six unrelated families with predominantly nonsyndromic XLMR. All duplications segregate with the disease, including the large families MRX17 and MRX31. The minimal, commonly duplicated region contains three genes: RIBC1, HSD17B10, and HUWE1. RIBC1 could be excluded on the basis of its absence of expression in the brain and because it escapes X inactivation in females. For the other genes, expression array and quantitative PCR analysis in patient cell lines compared to controls showed a significant upregulation of HSD17B10 and HUWE1 as well as several important genes in their molecular pathways. Loss-of-function mutations of HSD17B10 have previously been associated with progressive neurological disease and XLMR. The E3 ubiquitin ligase HUWE1 has been implicated in TP53-associated regulation of the neuronal cell cycle. Here, we also report segregating sequence changes of highly conserved residues in HUWE1 in three XLMR families; these changes are possibly associated with the phenotype. Our findings demonstrate that an increased gene dosage of HSD17B10, HUWE1, or both contribute to the etiology of XLMR and suggest that point mutations in HUWE1 are associated with this disease too.


American Journal of Human Genetics | 2007

Disruption of ROBO2 is associated with urinary tract anomalies and confers risk of vesicoureteral reflux

Weining Lu; Albertien M. van Eerde; Xueping Fan; Fabiola Quintero-Rivera; Shashikant Kulkarni; Heather L. Ferguson; Hyung Goo Kim; Yanli Fan; Qiongchao Xi; Qing Gang Li; Damien Sanlaville; William Andrews; Vasi Sundaresan; Weimin Bi; Jiong Yan; Jacques C. Giltay; Cisca Wijmenga; Tom P.V.M. de Jong; Sally Feather; Adrian S. Woolf; Yi Rao; James R. Lupski; Michael R. Eccles; Bradley J. Quade; James F. Gusella; Cynthia C. Morton; Richard L. Maas

Congenital anomalies of the kidney and urinary tract (CAKUT) include vesicoureteral reflux (VUR). VUR is a complex, genetically heterogeneous developmental disorder characterized by the retrograde flow of urine from the bladder into the ureter and is associated with reflux nephropathy, the cause of 15% of end-stage renal disease in children and young adults. We investigated a man with a de novo translocation, 46,X,t(Y;3)(p11;p12)dn, who exhibits multiple congenital abnormalities, including severe bilateral VUR with ureterovesical junction defects. This translocation disrupts ROBO2, which encodes a transmembrane receptor for SLIT ligand, and produces dominant-negative ROBO2 proteins that abrogate SLIT-ROBO signaling in vitro. In addition, we identified two novel ROBO2 intracellular missense variants that segregate with CAKUT and VUR in two unrelated families. Adult heterozygous and mosaic mutant mice with reduced Robo2 gene dosage also exhibit striking CAKUT-VUR phenotypes. Collectively, these results implicate the SLIT-ROBO signaling pathway in the pathogenesis of a subset of human VUR.


American Journal of Human Genetics | 2006

Contiguous Gene Deletion within Chromosome Arm 10q Is Associated with Juvenile Polyposis of Infancy, Reflecting Cooperation between the BMPR1A and PTEN Tumor-Suppressor Genes

Capucine Delnatte; Damien Sanlaville; Jean Francois Mougenot; Joris Vermeesch; Claude Houdayer; Marie Christine De Blois; David Geneviève; Olivier Goulet; Jean Pierre Fryns; Francis Jaubert; Michel Vekemans; Stanislas Lyonnet; Serge Romana; Charis Eng; Dominique Stoppa-Lyonnet

We describe four unrelated children who were referred to two tertiary referral medical genetics units between 1991 and 2005 and who are affected with juvenile polyposis of infancy. We show that these children are heterozygous for a germline deletion encompassing two contiguous genes, PTEN and BMPR1A. We hypothesize that juvenile polyposis of infancy is caused by the deletion of these two genes and that the severity of the disease reflects cooperation between these two tumor-suppressor genes.


American Journal of Human Genetics | 2004

Paradoxical NSD1 Mutations in Beckwith-Wiedemann Syndrome and 11p15 Anomalies in Sotos Syndrome

Geneviève Baujat; Marlène Rio; Sylvie Rossignol; Damien Sanlaville; Stanislas Lyonnet; Martine Le Merrer; Arnold Munnich; Christine Gicquel; Valérie Cormier-Daire; Laurence Colleaux

Sotos syndrome is an overgrowth syndrome characterized by pre- and postnatal overgrowth, macrocephaly, advanced bone age, variable degrees of mental retardation, and typical facial features. Defects of the NSD1 gene account for >or=60% of cases of Sotos syndrome, whereas the disease-causing mechanism of other cases remains unknown. Beckwith-Wiedemann syndrome (BWS) is a distinct overgrowth condition characterized by macroglossia, abdominal-wall defects, visceromegaly, embryonic tumors, hemihyperplasia, ear anomalies, renal anomalies, and neonatal hypoglycemia. Deregulation of imprinted growth-regulatory genes within the 11p15 region is the major cause of BWS, whereas the molecular defect underlying a significant proportion of sporadic BWS cases remains unknown. Owing to clinical overlaps between the two syndromes, we investigated whether unexplained cases of Sotos syndrome could be related to 11p15 anomalies and, conversely, whether unexplained BWS cases could be related to NSD1 deletions or mutations. Two 11p15 anomalies were identified in a series of 20 patients with Sotos syndrome, and two NSD1 mutations were identified in a series of 52 patients with BWS. These results suggest that the two disorders may have more similarities than previously thought and that NSD1 could be involved in imprinting of the chromosome 11p15 region.


Journal of Medical Genetics | 2004

NIPBL mutations and genetic heterogeneity in Cornelia de Lange syndrome

Guntram Borck; Richard Redon; Damien Sanlaville; Marlène Rio; M Prieur; Stanislas Lyonnet; Michel Vekemans; Nigel P. Carter; Arnold Munnich; Laurence Colleaux; Valérie Cormier-Daire

Cornelia de Lange syndrome (CdLS, also called Brachmann de Lange syndrome; OMIM 122470) is characterised by pre- and postnatal growth retardation, microcephaly, severe mental retardation with speech delay, feeding problems, major malformations including limb defects, and characteristic facial features.1 Facial dysmorphism includes arched eyebrows, synophrys, short nose with anteverted nares, long philtrum, thin upper lip, and micrognathia. Although few autosomal dominant forms of CdLS have been described,2,3 the large majority of cases are sporadic, and the scarcity of these familial forms has hampered the identification of the gene(s) underlying CdLS.4 Finally, rare cases of CdLS have been associated with balanced chromosomal translocations.5–7 A gene responsible for CdLS has been recently identified by two groups. Indeed, Krantz et al performed genome-wide linkage exclusion mapping in 12 CdLS families and identified a locus on chromosome 5p13.8 This locus mapped close to both a translocation breakpoint and a small de novo deletion associated with CdLS. Studying the 5p13 translocation breakpoint allowed both groups to identify a disrupted gene which they called NIPBL , for Nipped-B like.8,9 NIPBL is the human homolog of the Drosophila Nipped-B gene, the product of which belongs to the family of chromosomal adherins. The Drosophila Nipped-B protein is involved in chromatid cohesion processes and enhancer-promoter communication.10,11 The exact function of the human NIPBL gene product, called delangin, is unknown, but its wide expression pattern, including expression in embryonic limb bud, branchial arch, and craniofacial mesenchyme, is consistent with many of the anomalies observed in CdLS. NIPBL mutations have been identified in 20–50% of CdLS cases,8,9,12 suggesting that some mutations may have escaped detection and/or that CdLS is genetically heterogeneous. To address this question, we performed a comprehensive clinical, cytogenetic, and molecular study in 14 affected …


American Journal of Medical Genetics Part A | 2004

Atypical findings in Kabuki syndrome: Report of 8 patients in a series of 20 and review of the literature

David Geneviève; Jeanne Amiel; Géraldine Viot; M. Le Merrer; Damien Sanlaville; A. Urtizberea; Marion Gerard; Arnold Munnich; Valérie Cormier-Daire; Stanislas Lyonnet

Kabuki syndrome (KS) is a rare multiple congenital anomaly/mental retardation syndrome with an estimated frequency of 1/32,000 in Japan. Five major criteria delineate KS namely postnatal short stature, skeletal anomalies, moderate mental retardation, dermatoglyphic anomalies, and a characteristic facial dysmorphism. Here we report on a series of 20 sporadic KS patients and we focus on some rare and atypical features that we have observed: chronic and/or severe diarrhea (4/20) including celiac disease, diaphragmatic defects (3/20), pseudarthrosis of the clavicles (2/20), vitiligo (2/20), and persistent hypoglycemia (2/20). Other occasional findings were severe autoimmune thrombopenia, cerebellar vermis atrophy, and myopathic features. Interestingly, one of our KS patients presented with a clinical overlap with CHARGE syndrome (right eye microphtalmia with optic nerve coloboma, VSD, bilateral cryptorchidism, and severe deafness). Because these features are more frequent in our series than previously described, we propose to carefully investigate these manifestations during KS patient survey in an attempt to determine their real frequency and in order to improve clinical management.


Journal of Medical Genetics | 2005

Congenital hyperinsulinism and mosaic abnormalities of the ploidy

Irina Giurgea; Damien Sanlaville; J-C Fournet; Christine Sempoux; C. Bellanné-Chantelot; Guy Touati; Laurence Hubert; M-S Groos; Francis Brunelle; Jacques Rahier; Jean-Claude Henquin; Mark J. Dunne; Francis Jaubert; J.-J. Robert; Claire Nihoul-Fékété; Michel Vekemans; Claudine Junien; P. de Lonlay

Background: Congenital hyperinsulinism and Beckwith-Wiedemann syndrome both lead to β islet hyperplasia and neonatal hypoglycaemia. They may be related to complex genetic/epigenetic abnormalities of the imprinted 11p15 region. The possibility of common pathophysiological determinants has not been thoroughly investigated. Objective: To report abnormalities of the ploidy in two unrelated patients with congenital hyperinsulinism. Methods: Two patients with severe congenital hyperinsulinism, one overlapping with Beckwith-Wiedemann syndrome, had pancreatic histology, ex vivo potassium channel electrophysiological studies, and mutation detection of the encoding genes. The parental genetic contribution was explored using genome-wide polymorphism, fluorescent in situ hybridisation (FISH), and blood group typing studies. Results: Histological findings diverged from those described in focal congenital hyperinsulinism or Beckwith-Wiedemann syndrome. No potassium channel dysfunction and no mutation of its encoding genes (SUR1, KIR6.2) were detected. In patient 1 with congenital hyperinsulinism and Beckwith-Wiedemann syndrome, paternal isodisomy for the whole haploid set was homogeneous in the pancreatic lesion, and mosaic in the leucocytes and skin fibroblasts (hemihypertrophic segment). Blood group typing confirmed the presence of two erythroid populations (bi-parental v paternal only contribution). Patient 2 had two pancreatic lesions, both revealing triploidy with paternal heterodisomy. Karyotype and FISH analyses done on the fibroblasts and leucocytes of both patients were unremarkable (diploidy). Conclusions: Diploid (biparental/paternal-only) mosaicism and diploid/triploid mosaicism were present in two distinct patients with congenital hyperinsulinism. These chromosomal abnormalities led to paternal disomy for the whole haploid set in pancreatic lesions (with isodisomy or heterodisomy), thereby extending the range and complexity of the mechanisms underlying congenital hyperinsulinism, associated or not with Beckwith-Wiedemann syndrome.


American Journal of Medical Genetics Part A | 2003

Mild phenotype in a 15-year-old boy with Pallister–Killian syndrome

David Geneviève; Valérie Cormier-Daire; Damien Sanlaville; L. Faivre; Philippe Gosset; L. Allart; M. Picq; Arnold Munnich; S. Romana; M-C de Blois; Michel Vekemans

Pallister–Killian syndrome is a rare disorder characterized by multiple congenital anomalies, coarse face, pigmentary skin changes, seizures, severe mental retardation, and the presence of an extra metacentric chromosome i(12p) confined to skin fibroblasts only. Here, we report on an unusual case of i(12p) in a 15‐year‐old boy presenting with mild mental retardation, minor facial features (long face, prognathism, short neck), normal weight, length, and OFC parameters as well as hyperpigmented streaks. The boy attended normal school until the age of 14 years. Because of hyperpigmented stripes, chromosome analysis was performed on skin fibroblasts. This study showed that 37% of the cells had an additional isochromosome for the short arm of chromosome 12. This observation illustrates the phenotypic variability of i(12p) and emphasizes the importance of skin fibroblasts chromosome analysis in patients with pigmentary skin changes.

Collaboration


Dive into the Damien Sanlaville's collaboration.

Top Co-Authors

Avatar

Michel Vekemans

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

Arnold Munnich

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

Catherine Turleau

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

Laurence Colleaux

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

Stanislas Lyonnet

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

Marlène Rio

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

Valérie Cormier-Daire

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

S. Romana

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jeanne Amiel

Necker-Enfants Malades Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge